Poland’s Chief Pharmaceutical Inspector recalls counterfeit antiseptic from pharmacies after discovering illegal repackaging in supply chain.
GIF Recalls Octenisept 50 ml from Pharmacies
The Chief Pharmaceutical Inspectorate has decided to withdraw from circulation and prohibit the introduction of a popular antiseptic liquid. This concerns Octenisept in direct packaging in the form of a transparent bottle with a capacity of 50 ml.
Octenisept Batches Withdrawn from Circulation
According to the GIF message, the decision is related to a notification containing information about suspected counterfeiting of Octenisept in a 50 ml bottle. Products identified as counterfeit were discovered in the legal supply chain in Poland, available in retail pharmacies. Emergency inspections revealed 25 packages of the counterfeit product.
How Was Octenisept 50 ml Counterfeited in Pharmacies?
The counterfeiting involved illegally pouring the drug from large bulk bottles (1000 ml) into small, transparent 50 ml bottles. Labels that looked nearly identical to the originals were printed directly in one pharmacy. This constituted the division of larger packaging into smaller products.
Why Is Counterfeit Octenisept Dangerous?
GIF emphasizes that such action violates the law and poses a direct threat to consumer health and life. These pharmacy actions can undermine citizens’ trust in the healthcare system. Independently “dividing” the drug in non-sterile conditions violates the safety of the antiseptic preparation.
What to Do with Octenisept Withdrawn from Pharmacies?
Medicinal products identified as counterfeit must be immediately removed from pharmacy shelves. Patients should monitor GIF messages as the case is ongoing and affects trust in Poland’s entire healthcare system.
